ALLO – allogene therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year? [Yahoo! Finance]
Allogene Therapeutics (NASDAQ:ALLO) was upgraded by analysts at Citizens Jmp from a "market perform" rating to a "mkt outperform" rating. They now have a $5.00 price target on the stock.
Allogene Therapeutics (NASDAQ:ALLO) was upgraded by analysts at Citigroup Inc. from a "market perform" rating to an "outperform" rating.
Allogene Therapeutics (NASDAQ:ALLO) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T [Yahoo! Finance]
Form 4 Allogene Therapeutics, For: Dec 18 Filed by: Kazam Joshua A
Form 4 Allogene Therapeutics, For: Nov 17 Filed by: Beneski Benjamin Machinas
Form 144 Allogene Therapeutics, Filed by: Beneski Benjamin Machinas
Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Belldegrun Arie
Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Capital World Investors
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.